Treatment of essential blepharospasm with quetiapine
Identifieur interne : 001D94 ( Istex/Corpus ); précédent : 001D93; suivant : 001D95Treatment of essential blepharospasm with quetiapine
Auteurs : Roy R. Reeves ; Vincent LibertoSource :
- Movement Disorders [ 0885-3185 ] ; 2003-09.
English descriptors
- KwdEn :
Abstract
A 69‐year‐old male with blepharospasm unresponsive to several medications who was successfully treated with quetiapine is described. His symptoms were largely alleviated by low doses, but he experienced sedation, which permitted him to take the medication at bedtime only. © 2003 Movement Disorder Society
Url:
DOI: 10.1002/mds.10485
Links to Exploration step
ISTEX:859B812622B3A5B1E2D9FE616B9E3D9CC2F75C43Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of essential blepharospasm with quetiapine</title><author><name sortKey="Reeves, Roy R" sort="Reeves, Roy R" uniqKey="Reeves R" first="Roy R." last="Reeves">Roy R. Reeves</name><affiliation><mods:affiliation>University of Mississippi School of Medicine, and G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi, USA</mods:affiliation></affiliation></author><author><name sortKey="Liberto, Vincent" sort="Liberto, Vincent" uniqKey="Liberto V" first="Vincent" last="Liberto">Vincent Liberto</name><affiliation><mods:affiliation>University of Mississippi School of Medicine, and G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:859B812622B3A5B1E2D9FE616B9E3D9CC2F75C43</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1002/mds.10485</idno><idno type="url">https://api.istex.fr/document/859B812622B3A5B1E2D9FE616B9E3D9CC2F75C43/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001D94</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Treatment of essential blepharospasm with quetiapine</title><author><name sortKey="Reeves, Roy R" sort="Reeves, Roy R" uniqKey="Reeves R" first="Roy R." last="Reeves">Roy R. Reeves</name><affiliation><mods:affiliation>University of Mississippi School of Medicine, and G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi, USA</mods:affiliation></affiliation></author><author><name sortKey="Liberto, Vincent" sort="Liberto, Vincent" uniqKey="Liberto V" first="Vincent" last="Liberto">Vincent Liberto</name><affiliation><mods:affiliation>University of Mississippi School of Medicine, and G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2003-09">2003-09</date><biblScope unit="vol">18</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="1072">1072</biblScope><biblScope unit="page" to="1073">1073</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">859B812622B3A5B1E2D9FE616B9E3D9CC2F75C43</idno><idno type="DOI">10.1002/mds.10485</idno><idno type="ArticleID">MDS10485</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>blepharospasm</term><term>focal dystonia</term><term>quetiapine</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A 69‐year‐old male with blepharospasm unresponsive to several medications who was successfully treated with quetiapine is described. His symptoms were largely alleviated by low doses, but he experienced sedation, which permitted him to take the medication at bedtime only. © 2003 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Roy R. Reeves DO, PhD</name><affiliations><json:string>University of Mississippi School of Medicine, and G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi, USA</json:string></affiliations></json:item><json:item><name>Vincent Liberto MD</name><affiliations><json:string>University of Mississippi School of Medicine, and G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi, USA</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>blepharospasm</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>quetiapine</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>focal dystonia</value></json:item></subject><language><json:string>eng</json:string></language><abstract>A 69‐year‐old male with blepharospasm unresponsive to several medications who was successfully treated with quetiapine is described. His symptoms were largely alleviated by low doses, but he experienced sedation, which permitted him to take the medication at bedtime only. © 2003 Movement Disorder Society</abstract><qualityIndicators><score>5.528</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>305</abstractCharCount><pdfWordCount>15720</pdfWordCount><pdfCharCount>101320</pdfCharCount><pdfPageCount>22</pdfPageCount><abstractWordCount>44</abstractWordCount></qualityIndicators><title>Treatment of essential blepharospasm with quetiapine</title><genre><json:string>Serial article</json:string></genre><host><volume>18</volume><pages><total>2</total><last>1073</last><first>1072</first></pages><issn><json:string>0885-3185</json:string></issn><issue>9</issue><subject><json:item><value>Clinical/Scientific Note</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2003</publicationDate><copyrightDate>2003</copyrightDate><doi><json:string>10.1002/mds.10485</json:string></doi><id>859B812622B3A5B1E2D9FE616B9E3D9CC2F75C43</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/859B812622B3A5B1E2D9FE616B9E3D9CC2F75C43/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/859B812622B3A5B1E2D9FE616B9E3D9CC2F75C43/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/859B812622B3A5B1E2D9FE616B9E3D9CC2F75C43/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Treatment of essential blepharospasm with quetiapine</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>2003</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Treatment of essential blepharospasm with quetiapine</title><author><persName><forename type="first">Roy R.</forename><surname>Reeves</surname><roleName type="degree">DO, PhD</roleName></persName><note type="correspondence"><p>Correspondence: VA Medical Center, 1500 E. Woodrow Wilson Drive, Jackson, MS 39216</p></note><affiliation>University of Mississippi School of Medicine, and G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi, USA</affiliation></author><author><persName><forename type="first">Vincent</forename><surname>Liberto</surname><roleName type="degree">MD</roleName></persName><affiliation>University of Mississippi School of Medicine, and G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi, USA</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2003-09"></date><biblScope unit="vol">18</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="1072">1072</biblScope><biblScope unit="page" to="1073">1073</biblScope></imprint></monogr><idno type="istex">859B812622B3A5B1E2D9FE616B9E3D9CC2F75C43</idno><idno type="DOI">10.1002/mds.10485</idno><idno type="ArticleID">MDS10485</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2003</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>A 69‐year‐old male with blepharospasm unresponsive to several medications who was successfully treated with quetiapine is described. His symptoms were largely alleviated by low doses, but he experienced sedation, which permitted him to take the medication at bedtime only. © 2003 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>blepharospasm</term></item><item><term>quetiapine</term></item><item><term>focal dystonia</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Clinical/Scientific Note</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2002-10-10">Received</change><change when="2003-02-14">Registration</change><change when="2003-09">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/859B812622B3A5B1E2D9FE616B9E3D9CC2F75C43/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="90"><doi origin="wiley" registered="yes">10.1002/mds.v18:9</doi><numberingGroup><numbering type="journalVolume" number="18">18</numbering><numbering type="journalIssue">9</numbering></numberingGroup><coverDate startDate="2003-09">September 2003</coverDate></publicationMeta><publicationMeta level="unit" type="shortCommunication" position="210" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.10485</doi><idGroup><id type="unit" value="MDS10485"></id></idGroup><countGroup><count type="pageTotal" number="2"></count></countGroup><titleGroup><title type="articleCategory">Clinical/Scientific Note</title><title type="tocHeading1">Clinical/Scientific Notes</title></titleGroup><copyright ownership="thirdParty">Copyright © 2003 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2002-10-10"></event><event type="manuscriptRevised" date="2003-01-06"></event><event type="manuscriptAccepted" date="2003-02-14"></event><event type="publishedOnlineEarlyUnpaginated" date="2003-04-24"></event><event type="firstOnline" date="2003-04-24"></event><event type="publishedOnlineFinalForm" date="2003-09-02"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:FullText result:FullText" date="2010-03-09"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">1072</numbering><numbering type="pageLast">1073</numbering></numberingGroup><correspondenceTo>VA Medical Center, 1500 E. Woodrow Wilson Drive, Jackson, MS 39216</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS10485.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="11"></count><count type="wordTotal" number="1093"></count></countGroup><titleGroup><title type="main" xml:lang="en">Treatment of essential blepharospasm with quetiapine</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Roy R.</givenNames><familyName>Reeves</familyName><degrees>DO, PhD</degrees></personName><contactDetails><email>roy.reeves@med.va.gov</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Vincent</givenNames><familyName>Liberto</familyName><degrees>MD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>University of Mississippi School of Medicine, and G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi, USA</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">blepharospasm</keyword><keyword xml:id="kwd2">quetiapine</keyword><keyword xml:id="kwd3">focal dystonia</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>A 69‐year‐old male with blepharospasm unresponsive to several medications who was successfully treated with quetiapine is described. His symptoms were largely alleviated by low doses, but he experienced sedation, which permitted him to take the medication at bedtime only. © 2003 Movement Disorder Society</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 3-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Treatment of essential blepharospasm with quetiapine</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Treatment of essential blepharospasm with quetiapine</title></titleInfo><name type="personal"><namePart type="given">Roy R.</namePart><namePart type="family">Reeves</namePart><namePart type="termsOfAddress">DO, PhD</namePart><affiliation>University of Mississippi School of Medicine, and G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi, USA</affiliation><description>Correspondence: VA Medical Center, 1500 E. Woodrow Wilson Drive, Jackson, MS 39216</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Vincent</namePart><namePart type="family">Liberto</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>University of Mississippi School of Medicine, and G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">shortCommunication</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2003-09</dateIssued><dateCaptured encoding="w3cdtf">2002-10-10</dateCaptured><dateValid encoding="w3cdtf">2003-02-14</dateValid><copyrightDate encoding="w3cdtf">2003</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">11</extent><extent unit="words">1093</extent></physicalDescription><abstract lang="en">A 69‐year‐old male with blepharospasm unresponsive to several medications who was successfully treated with quetiapine is described. His symptoms were largely alleviated by low doses, but he experienced sedation, which permitted him to take the medication at bedtime only. © 2003 Movement Disorder Society</abstract><subject lang="en"><genre>Keywords</genre><topic>blepharospasm</topic><topic>quetiapine</topic><topic>focal dystonia</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Clinical/Scientific Note</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><detail type="issue"><caption>no.</caption><number>9</number></detail><extent unit="pages"><start>1072</start><end>1073</end><total>2</total></extent></part></relatedItem><identifier type="istex">859B812622B3A5B1E2D9FE616B9E3D9CC2F75C43</identifier><identifier type="DOI">10.1002/mds.10485</identifier><identifier type="ArticleID">MDS10485</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2003 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D94 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001D94 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:859B812622B3A5B1E2D9FE616B9E3D9CC2F75C43
|texte= Treatment of essential blepharospasm with quetiapine
}}
| This area was generated with Dilib version V0.6.23. |  |